Login / Signup

Utilisation of systemic therapy options in routine treatment of metastatic colorectal cancer in Australia.

Rachel DelahuntyMargaret LeeHui-Li WongJulie JohnsJoseph MckendrickBelinda LeeSuzanne KosmiderPrasad CooraySumitra AnandaJayesh DesaiBen TranJeanne TiePeter GibbsRachel Wong
Published in: Internal medicine journal (2021)
In this community-based cohort, 33% of patients had not received any systemic therapy for mCRC, and few patients had received all available active systemic agents. As many patients remain alive, these figures will likely increase over time. The overall survival of patients with mCRC in this community-based cohort was 25 months and not dissimilar to that achieved in recent clinical trials.
Keyphrases